Skip to main content
  • About API
    • About API

    • About API
    • Leadership & Team
    • Facilities
      • Facilities

      • Biohubx
      • Biotechnology Business Development Centre
      • Drug Development and Innovation Centre
      • Pharmaceutical Analysis Laboratory (PAL)
    • Careers
      • Careers

      • Working at API
  • What We Do
    • What We Do

    • Ecosystem Initiatives
      • Ecosystem Initiatives

      • Training & Programs
      • Canadian Critical Drug Initiative
      • Life Sciences Week
      • Life Sciences Investment Summit
    • CDMO Services
      • CDMO Services

      • Products
      • Sterile Fill Finish
      • Oral Dosage Manufacturing
      • Topical Application Manufacturing
      • Natural Health Products
      • Active Ingredients
      • Small Molecule Manufacturing
      • Highly Potent Controlled Substances
    • CRO Services
      • CRO Services

      • Research Development
      • Regulatory & Quality
      • Clinical & Quantitative Solutions
    • Products Supported
      • Products Supported

      • Pharmaceuticals & Biologics
      • Medical Devices & Diagnostics
      • Health Technologies
    • View all programsCheck out all of the programs API has to offer.
  • News
  • Events
  • Contact
  • News

The latest from API

Find out the latest news, announcements, and stories from API and Alberta’s life sciences sector. Stay in the know by subscribing below!

  • All
  • CCDI
  • Incubated Companies
  • Innovation Translated
  • Life Sciences Week
  • News
  • Newsletter
  • Stories

Posted: May 4, 2022

  • News

API joins the Edmonton delegation for the San Francisco Trade Mission

Read moreabout API joins the Edmonton delegation for the San Francisco Trade Mission

Posted: Apr 28, 2022

  • News

API partners with a University of Saskatchewan scientist to discover and develop novel antivirals against emerging Coronavirus variants

Read moreabout API partners with a University of Saskatchewan scientist to discover and develop novel antivirals against emerging Coronavirus variants

Posted: Apr 25, 2022

  • Stories

Micheal Guirguis, Director, Clinical Pharmacology & Data: The regulatory and financial gap

Read moreabout Micheal Guirguis, Director, Clinical Pharmacology & Data: The regulatory and financial gap

Posted: Apr 22, 2022

  • News

API participates in ‘Transformations in Health Technologies’ panel at the Alberta Technology Symposium

Read moreabout API participates in ‘Transformations in Health Technologies’ panel at the Alberta Technology Symposium

Posted: Apr 15, 2022

  • News

API joins the Edmonton delegation for the Nashville Business & Tourism Trade Mission

Read moreabout API joins the Edmonton delegation for the Nashville Business & Tourism Trade Mission

Posted: Mar 31, 2022

  • News

Applied Pharmaceutical Innovation (API) announces establishment of team with researchers from Nova Scotia Universities for antiviral drug discovery against SARS-CoV-2 and RNA viruses

Read moreabout Applied Pharmaceutical Innovation (API) announces establishment of team with researchers from Nova Scotia Universities for antiviral drug discovery against SARS-CoV-2 and RNA viruses

Posted: Mar 29, 2022

  • Stories

Hana Marinkovic, Director of Corporate Affairs: Helping People Live to Their Greatest Potential

Read moreabout Hana Marinkovic, Director of Corporate Affairs: Helping People Live to Their Greatest Potential

Posted: Mar 22, 2022

  • News

Nobel Laureate and member of API Scientific Advisory Committee, Dr. Michael Houghton recognized in the Alberta Bioindustry Hall of Fame

Read moreabout Nobel Laureate and member of API Scientific Advisory Committee, Dr. Michael Houghton recognized in the Alberta Bioindustry Hall of Fame

Posted: Mar 22, 2022

  • Stories

Applied Pharmaceutical Innovation (API) completes clinical trial material production for the ‘Canadian Maraviroc Randomized Controlled Trial to Augment Rehabilitation Outcomes After Stroke’ (CAMAROS) study

Read moreabout Applied Pharmaceutical Innovation (API) completes clinical trial material production for the ‘Canadian Maraviroc Randomized Controlled Trial to Augment Rehabilitation Outcomes After Stroke’ (CAMAROS) study

Posted: Mar 16, 2022

  • News

Pfizer, Applied Pharmaceutical Innovation and University of Alberta launch the Pfizer Applied Clinical Pharmacology Program

Read moreabout Pfizer, Applied Pharmaceutical Innovation and University of Alberta launch the Pfizer Applied Clinical Pharmacology Program

Posted: Mar 14, 2022

  • News

Home-Grown Talent: Brian Corrigan, Global Head, Clinical Pharmacology, Pfizer and member of API’s Scientific Advisory Committee

Read moreabout Home-Grown Talent: Brian Corrigan, Global Head, Clinical Pharmacology, Pfizer and member of API’s Scientific Advisory Committee

Posted: Mar 4, 2022

  • News

Micheal Guirguis, Director, Clinical and Data Services: Why Is Drug Development Important?

Read moreabout Micheal Guirguis, Director, Clinical and Data Services: Why Is Drug Development Important?

Posted: Feb 22, 2022

  • News

API joins the Canadian Chamber of Commerce-Member network and the Life Sciences Strategy Council

Read moreabout API joins the Canadian Chamber of Commerce-Member network and the Life Sciences Strategy Council

Posted: Feb 18, 2022

  • News

Govt of Alberta announces of ‘The Edmonton Metro Region Economic Recovery (EMRER)’ Working Group

Read moreabout Govt of Alberta announces of ‘The Edmonton Metro Region Economic Recovery (EMRER)’ Working Group

Posted: Feb 11, 2022

  • News

Archana Koul, Scientist, API: Interacting with the life sciences industry

In this video, Archana Koul, Scientist (S1) shares her experience of working…

Read moreabout Archana Koul, Scientist, API: Interacting with the life sciences industry

Posted: Feb 3, 2022

  • News

Canurta Inc. announces partnership with Applied Pharmaceutical Innovation (API) and Dr. Neal M. Davies of University of Alberta for novel hemp polyphenols-based drug discoveries

Read moreabout Canurta Inc. announces partnership with Applied Pharmaceutical Innovation (API) and Dr. Neal M. Davies of University of Alberta for novel hemp polyphenols-based drug discoveries
Previous Page
1 … 4 5 6 7 8 … 10
Next Page

Get industry news and updates from API

Sign up to receive the latest news from API including partnerships, programs, press releases and our monthly newsletter.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
API Branding Badge

Applied Pharmaceutical Innovation

Copyright © 2026

  • About Us
  • What we do
  • Programs
  • News
  • Events
  • Connect

API is headquartered in Edmonton, Alberta on Treaty 6 territory and the home of many First Nations, Metis, Inuit and other First Peoples of Canada whose histories, languages, and cultures are integral to the vibrance of communities across Canada.

Terms of Service

|

Privacy Policy